CLINICAL_TRIALS
trial_result
· 2015-11-13
Clinical Trial Update: Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial comparing NN1250 to insulin glargine in adults with type 2 diabetes; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2015-11-13